MindMed | Investor Presentation Deck | 28 slides · page 19 of 28
The slide outlines two study arms (MM120 ODT 100 µg and Placebo) with a primary endpoint at week 6, followed by a 40-week extension.
Pitch deck · appendix_methodology · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 6/6
diagram 1/1 image 1/1 paragraph 2/2 source-note 1/1 title 1/1
Components 6
process logo paragraph paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1